HCA Healthcare (NYSE:HCA) Price Target Raised to $155.00 at Jefferies Financial Group

Share on StockTwits

HCA Healthcare (NYSE:HCA) had its price target increased by equities research analysts at Jefferies Financial Group to $155.00 in a research note issued to investors on Friday, September 21st, The Fly reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s target price would suggest a potential upside of 15.79% from the stock’s previous close. Jefferies Financial Group also issued estimates for HCA Healthcare’s FY2020 earnings at $11.50 EPS.

A number of other research analysts have also issued reports on HCA. ValuEngine lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, June 28th. SunTrust Banks raised their price target on shares of HCA Healthcare to $145.00 and gave the stock a “buy” rating in a research report on Thursday, July 26th. Barclays initiated coverage on shares of HCA Healthcare in a research report on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 price target on the stock. Cantor Fitzgerald restated a “buy” rating and issued a $115.00 price target on shares of HCA Healthcare in a research report on Friday, July 20th. Finally, Mizuho restated a “buy” rating and issued a $145.00 price target on shares of HCA Healthcare in a research report on Thursday, August 2nd. Two analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $135.19.

NYSE:HCA opened at $133.86 on Friday. HCA Healthcare has a 1 year low of $71.18 and a 1 year high of $141.11. The company has a current ratio of 1.36, a quick ratio of 1.15 and a debt-to-equity ratio of -7.64. The firm has a market capitalization of $48.14 billion, a P/E ratio of 20.31, a PEG ratio of 1.23 and a beta of 0.49.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.16 by $0.13. HCA Healthcare had a net margin of 6.21% and a negative return on equity of 61.68%. The business had revenue of $11.53 billion for the quarter, compared to analyst estimates of $11.32 billion. During the same period last year, the business posted $1.73 EPS. HCA Healthcare’s revenue was up 7.4% compared to the same quarter last year. Research analysts forecast that HCA Healthcare will post 9.23 EPS for the current year.

In other news, SVP Kathryn A. Torres sold 1,530 shares of HCA Healthcare stock in a transaction dated Friday, July 27th. The shares were sold at an average price of $124.47, for a total transaction of $190,439.10. Following the sale, the senior vice president now directly owns 9,307 shares in the company, valued at approximately $1,158,442.29. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Kathryn A. Torres sold 1,689 shares of HCA Healthcare stock in a transaction dated Wednesday, July 25th. The shares were sold at an average price of $112.53, for a total transaction of $190,063.17. Following the sale, the senior vice president now owns 10,057 shares in the company, valued at $1,131,714.21. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 170,257 shares of company stock worth $21,118,053. 2.80% of the stock is owned by company insiders.

Several institutional investors have recently modified their holdings of the company. FMR LLC lifted its holdings in HCA Healthcare by 54.9% during the 2nd quarter. FMR LLC now owns 5,488,273 shares of the company’s stock valued at $563,097,000 after purchasing an additional 1,944,961 shares during the last quarter. LSV Asset Management lifted its holdings in HCA Healthcare by 9.2% during the 2nd quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock valued at $560,133,000 after purchasing an additional 457,752 shares during the last quarter. Northern Trust Corp lifted its holdings in HCA Healthcare by 4.2% during the 2nd quarter. Northern Trust Corp now owns 3,460,267 shares of the company’s stock valued at $355,023,000 after purchasing an additional 138,135 shares during the last quarter. Millennium Management LLC lifted its holdings in HCA Healthcare by 32.3% during the 2nd quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock valued at $174,270,000 after purchasing an additional 414,877 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its holdings in HCA Healthcare by 5.6% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 1,222,343 shares of the company’s stock valued at $125,413,000 after purchasing an additional 64,426 shares during the last quarter. Institutional investors and hedge funds own 70.40% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Read More: Stock Symbols, CUSIP and Other Stock Identifiers

The Fly

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply